OPNT: Data from OPNT003 Pharmacodynamic Trial in 2Q22…
By David Bautz, PhD
NASDAQ:OPNT
READ THE FULL OPNT RESEARCH REPORT
MDNA: No Read-Through for MDNA11 Based on Nektar Failure…
By David Bautz, PhD
NASDAQ:MDNA
READ THE FULL MDNA RESEARCH REPORT
TLSA: KOL Discussion and SPMS 6-Month Results
By John Vandermosten, CFA
NASDAQ:TLSA
Introduction
BRAG: Bragg Grows Q4 14% Despite German Headwinds, Looks Forward to Canadian Launch
By Lisa Thompson
NASDAQ:BRAG
READ THE FULL BRAG RESEARCH REPORT
ABVC: Lead Products Move Closer To Potential Approval; Important Clinical Studies Advancing
By M. Marin
NASDAQ:ABVC
READ THE FULL ABVC RESEARCH REPORT
WKSP: Worksport updates investors and stakeholders with multiple press releases
By Thomas Kerr, CFA
NASDAQ:WKSP
READ THE FULL WKSP RESEARCH REPORT
DRIO: Future Brightens with $40M Raise & Sanofi Deal
By John Vandermosten, CFA
NASDAQ:DRIO
READ THE FULL DRIO RESEARCH REPORT
NOVN: A Banner Year for Novan – 2021 Results
By John Vandermosten, CFA
NASDAQ:NOVN
READ THE FULL NOVN RESEARCH REPORT